Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
IntroductionThis study aimed to assess the diagnostic efficacy of the PRIMARY score, based on the 18F-labeled prostate-specific membrane antigen (PSMA-1007) positron emission tomography (PET)/computed tomography (CT) with multiparametric magnetic resonance imaging (mpMRI) PI-RADS, in detecting clini...
Saved in:
| Main Authors: | Zhilong Ma, HaiTong Hao, Jian Chen, Tong Pan, Qian Zhao, YanMei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1589212/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01) -
Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer
by: Eduards Mamlins, et al.
Published: (2025-05-01) -
Furosemide Reduces Radionuclide Activity in the Bladder in <sup>18</sup>F-PSMA-1007-PET/CT: A Single-Center Retrospective Intra-Individual Comparative Study
by: Martin A. Cahenzli, et al.
Published: (2025-07-01) -
Diagnostic value of 18F-PSMA-1007 PET/CT for predicting the pathological grade of prostate cancer
by: Xiao-Bo Niu, et al.
Published: (2024-12-01) -
Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study
by: Philip Alexander Glemser, et al.
Published: (2024-11-01)